Development and in vitro evaluation of micronized sustained release matrix tablet of carvedilol
Carvedilol, a non selective β blocking drug under the biopharmaceutical classification system (BCS) class II, is widely used in the treatment of hypertension. Solubility of this drug is very low which affects in low dissolution rate and in turn affect the bioavailability of this drug following oral...
Saved in:
Main Authors: | Chatterjee, Bappaditya, Pal, Tapan |
---|---|
Format: | Article |
Language: | English |
Published: |
International Journal of Pharmaceutical Sciences and Research (IJPSR)
2010
|
Subjects: | |
Online Access: | http://irep.iium.edu.my/31898/1/Paper1.pdf http://irep.iium.edu.my/31898/ http://www.ijpsr.com/V1I10/index.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Micronized carvedilol SR matrix tablet for improved dissolution
by: Chatterjee, Bappaditya
Published: (2016) -
Pharmacokinetic and sub-chronic toxicity study of a fixed dose combination and a sustained release tablet
by: Chatterjee, Bappaditya, et al.
Published: (2017) -
Physical properties and in vitro studies of sustained-release ketoprofen matrix tablets
by: Ibrahim Ijang,, et al.
Published: (2010) -
Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans
by: Herman, R.B., et al.
Published: (2003) -
Design And Evaluation Of Prolonged Release Gliclazide
Matrix Tablets.
by: Abdelraziq Abdelkareem Adam, Fathelrahman
Published: (2007)